Presentation TCT 2015 CE-Approved or EU Studies: JenaValve Technology Review and Clinical Update (JUPITER Trials) Presenter: Martin B. Leon, Nicolo Piazza, Hendrik Treede October 14, 2015
Presentation TCT 2015 Reversal Agents for Factor Xa Inhibitors Presenter: Lisa K. Jennings, Matthew T. Roe October 14, 2015
Presentation TCT 2015 Rivaroxaban: Analysis of Efficacy, Safety, and Special Considerations Presenter: Lisa K. Jennings, Matthew T. Roe, Manesh R. Patel October 14, 2015
Presentation TCT 2015 Apixaban: Analysis of Efficacy, Safety, and Special Considerations Presenter: Lisa K. Jennings, Matthew T. Roe October 14, 2015
Presentation TCT 2015 Dabigatran: Analysis of Efficacy, Safety, and Special Considerations (Including Reversal Agents) Presenter: Lisa K. Jennings, Matthew T. Roe, Pascal Vranckx October 14, 2015
Presentation TCT 2015 Big Data: Opportunities and Challenges 4 Academia Perspectives Presenter: Roxana Mehran, Laura Mauri October 13, 2015
Presentation TCT 2015 Big Data: Opportunities and Challenges 3 Industry Perspectives Presenter: Roxana Mehran, Keith D. Dawkins October 13, 2015
Presentation TCT 2015 Big Data: Opportunities and Challenges 2 EMA Perspectives Presenter: Roxana Mehran, Angeles Alonso Garcia October 13, 2015
Presentation TCT 2015 Big Data: Opportunities and Challenges 1 FDA Perspectives Presenter: Roxana Mehran, John C Laschinger October 13, 2015
Presentation TCT 2015 Is the Answer Pragmatic/Simple Trials? Are They Really So Simple? Presenter: Roxana Mehran, Robert A. Harrington October 13, 2015
Presentation TCT 2015 Life After the RIBS Trials: A Critical Overview of the Data and Implications for Clinical Practice Presenter: Juan F. Granada, Bruno Scheller, Fernando Alfonso October 13, 2015
Presentation TCT 2015 Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence Presenter: Ajay J. Kirtane, Roxana Mehran, Sanjay Kaul October 12, 2015
Presentation TCT 2015 HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Clinician/Trialist Perspective Presenter: Ajay J. Kirtane, Roxana Mehran, Robert A. Harrington October 12, 2015
Presentation TCT 2015 HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Statistical Perspective Presenter: Ajay J. Kirtane, Roxana Mehran, Eugene H. Blackstone October 12, 2015
Presentation TCT 2015 Keynote Lecture 2: The Case for (and the Arguments Against) Moving Quality-of-Life Assessment Front and Center in Clinical Trials Presenter: Ajay J. Kirtane, Roxana Mehran, John A. Spertus October 12, 2015
Presentation TCT 2015 HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective Presenter: Bernard J. Gersh, William S. Weintraub, Ajay J. Kirtane October 12, 2015
Presentation TCT 2015 HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective Presenter: Bernard J. Gersh, William S. Weintraub, Patrick T. O'Gara October 12, 2015
Presentation TCT 2015 HOT TOPIC 1: Should Small Randomized Trials Be Practice Changing? FOCUS on PRAMI and WOEST Clinician's Perspective Presenter: Bernard J. Gersh, William S. Weintraub, Eric R. Bates October 12, 2015
Presentation TCT 2015 HOT TOPIC 1: Should Small Randomized Trials Be Practice Changing? FOCUS on PRAMI and WOEST Trialist/Guideline Perspective Presenter: Bernard J. Gersh, William S. Weintraub, John A. Bittl October 12, 2015
Presentation TCT 2015 A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention Presenter: Shigeru Saito, Gregg W. Stone, Ron Waksman, Shigeru Saito October 12, 2015